Endometrial ILKAP expression among patients with endometriosis and its association with clinical characteristics
article
OA: closed
CC0
AI-generated summary
Endometrial ILKAP expression was lower in endometriosis patients than controls, and reduced ectopic ILKAP correlated with more severe clinical endometriosis characteristics.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To investigate expression of ILKAP among women with endometriosis and its association with clinical characteristics. METHODS: A retrospective study was conducted at a center in China in 2012, using samples of ectopic (n=55) and eutopic (n=33) endometrium from women with endometriosis, and control endometrium samples (n=33) from women without endometriosis. Information on clinical characteristics was obtained from records. The expression of ILKAP was tested by immunohistochemistry. RESULTS: The expression of ILKAP was higher in the secretory phase of the menstrual cycle than in the proliferative phase, and it was lower in eutopic and ectopic endometriosis tissue than in control endometrium (P<0.001 for both). A lower expression of ILKAP in ectopic endometrium was associated with moderate-to-severe dysmenorrhea, infertility for more than 1year, a cancer antigen 125 level of more than 35 U/mL, a disease duration of at least 1year, and American Fertility Society grade IV disease (P<0.05 for all). CONCLUSION: A low level of ILKAP could facilitate the pathogenesis of endometriosis. Additionally, the level of ILKAP expression in ectopic endometrium might reflect the severity of endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (23)
- Endometriosis: hormone regulation and clinical consequences of chemotaxis and apoptosis via openalex
- Growth mechanisms of endometriotic cells in implanted places: a review via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Reduction of apoptosis and proliferation in endometriosis via openalex
- The Complementary and Alternative Medicine for Endometriosis: A Review of Utilization and Mechanism via openalex
- W2048288183 via openalex
- W2052973604 via openalex
- W2068094391 via openalex
- W2072630322 via openalex
- W2074598967 via openalex
- W2075811389 via openalex
- W2077162807 via openalex
- W2092310663 via openalex
- W2114286114 via openalex
- W2125282776 via openalex
- W2137022580 via openalex
- W2168128490 via openalex
- W1551611947 via openalex
- W2325413783 via openalex
- W1969399733 via openalex
- W2003759862 via openalex
- W2030774127 via openalex
- W2032644533 via openalex
Source provenance
- europepmc
- last seen: 2026-06-13T06:22:48.782012+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:17:58.238279+00:00
License: CC0
· commercial use OK